4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-24-083403
Chief Technology Officer sold 13,330 shares at $5.97 ($79,625)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tyagarajan Seshu Chief Technology Officer | 2024-07-11 | Sale | −13,330 | $5.97 | $79,625 | 160,900 | D |
| Open-market sales · 13,330 sh · avg $5.97 · $79,625 | |||||||
Loading xslF345X05/ownership.xml…